Essure Lawsuit Commercial By Arobiyahinstitute

Rate this post


Essure Lawsuit Commercial By Arobiyahinstitute: Arobiyah Institute has recently launched a commercial shedding light on Essure lawsuits, aiming to inform and empower viewers about the legal actions surrounding this contraceptive device. Let’s delve into the key aspects highlighted by the Arobiyah Institute in their commercial.

Essure Lawsuits Explained:

In the commercial, Arobiyah Institute outlines the ongoing legal battles associated with Essure, a contraceptive implant. The institute underscores the significance of these lawsuits in addressing concerns and potential complications linked to the use of Essure.

essure lawsuit commercial by arobiyahinstitute
essure lawsuit commercial by arobiyahinstitute

Safety Concerns and Side Effects:

The commercial emphasizes the importance of understanding the safety concerns and potential side effects associated with Essure. Arobiyah Institute aims to raise awareness about the alleged adverse effects that some users have experienced, leading to legal actions against the device’s manufacturer.

Empowering Users:

Arobiyah Institute’s commercial is designed to empower users with knowledge. By providing information on Essure lawsuits, the institute aims to assist individuals in making informed decisions about their health and well-being.

Seeking Compensation:

The commercial touches upon the aspect of seeking compensation for those who have faced complications due to Essure. Arobiyah Institute encourages affected individuals to explore their legal rights and options to ensure they receive the compensation they deserve.

How to Stay Informed:

Arobiyah Institute wraps up the commercial by encouraging viewers to stay informed about Essure lawsuits. Whether through online resources, legal consultations, or support groups, the institute underscores the importance of staying updated on developments related to Essure and its legal implications.


Arobiyah Institute’s Essure lawsuit commercial serves as a valuable resource for individuals seeking information about the ongoing legal actions surrounding this contraceptive device. By presenting facts in an easy-to-understand manner, the institute empowers viewers to make informed decisions about their health and legal rights in the context of Essure.


In recent years, the ⁣Essure birth ‌control device has been at the center of controversy and litigation. The device, manufactured by Bayer Healthcare, has been the subject of numerous lawsuits, with thousands of women claiming ⁤that it caused them severe and sometimes irreversible health problems. ⁢In response to this, the renowned Shariah study institute, Arobiyahinstitute, has launched a commercial campaign highlighting the​ potential dangers of⁣ the Essure ⁣device and ‍calling for justice for the affected women.


Essure is ⁤a form of permanent birth control for⁢ women, ‌consisting ‌of two small metal coils inserted into the‍ fallopian tubes. It is marketed as a safe and non-surgical alternative to ⁢tubal ligation, with a success rate of over 99%. However,⁤ thousands of women have reported severe side effects, including chronic⁤ pain, migration of the device, and even unexplained miscarriages.

Despite the numerous complaints, the device was approved ‍by the U.S. ⁤Food‍ and Drug Administration (FDA) ‍in 2002, using the 510(k) ​fast-track approval ​process. This process‍ does not require clinical trials for approval, as it is deemed a⁤ “low to moderate risk” device. As a result, Bayer was ⁤able to release the Essure device to ⁣the ⁤market without thoroughly testing its safety and effectiveness.

Arobiyahinstitute’s Commercial

In response to the growing number of lawsuits against‍ Bayer,⁤ Arobiyahinstitute has launched a powerful commercial ⁢campaign to raise awareness ⁤about the dangers of Essure and to show solidarity with the affected ⁢women. The commercial features real women ​who have experienced ⁢health issues after using Essure, sharing their ⁤personal stories and calling for ⁢accountability from Bayer.

The⁤ commercial begins with a group of women sitting and talking together, with one woman ​stating, ​”I trusted⁤ Essure to protect me, but it ruined my life.” The camera then ⁢zooms in on each woman, as they share their stories of chronic pain, miscarriages, and even hysterectomies. They all express their frustration and anger ⁤towards Bayer for disregarding their health and ⁤well-being.

The​ commercial also highlights the lack of oversight by the FDA, as one woman states, “The FDA approved this device without any​ clinical trials. ‌How many more ⁤women have to‍ suffer before they take action?” The​ question remains, how did this device, with ‌so many reported⁤ issues, get approved in the⁤ first place? Arobiyahinstitute’s commercial demands answers​ and justice for the affected women.

Importance ‌of‌ Arobiyahinstitute’s Campaign

Arobiyahinstitute’s commercial is a crucial step towards raising awareness about the dangers of Essure and holding Bayer‌ accountable for their⁤ actions. The campaign ⁤has already gained significant attention, ⁣with many news outlets covering the story. As a respected institution within the Muslim community, Arobiyahinstitute’s​ involvement in this issue has given ⁤a voice to ⁣many women who have suffered in silence.

Not only does the campaign highlight ⁤the importance of‍ thorough ​testing and oversight by regulatory bodies, ​but also the need for ethical and​ responsible actions from pharmaceutical companies. The affected women deserve ‌justice, ​and ⁣Arobiyahinstitute’s commercial is a powerful⁤ call to action for ​Bayer to take responsibility for the ‌harm caused by⁣ Essure.


In conclusion, Arobiyahinstitute’s commercial is a powerful message ​that sheds light on the ongoing Essure lawsuit⁢ and demands justice ‍for the affected women. By bringing attention to ‍this ‍issue, Arobiyahinstitute is not only standing in solidarity with⁤ the victims but also advocating for reform in the process⁤ of medical device approval. It is time ⁤for Bayer to take ⁢responsibility ‍for the‍ harm caused by Essure and ​for the FDA to‌ re-evaluate its approval process to prevent similar incidents in the future.

Leave a Comment